Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Alkem Laboratories Ltd - 539523 - Outcome Of Board Meeting Dated 07Th February, 2020

 Pursuant to Reg 30 read with Reg 33 & 42 of the SEBI(LODR) Reg,2015,the Board of Directors, at its meeting held today, has inter alia: a.Approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31st December,2019. b.Declared Interim Dividend of Rs 22/- per equity share on the face value of Rs. 2/- per share for the financial year 2019-20 pursuant to Reg 43 read with Reg 30 of the Listing Regulations. c. Approved the re-appointment and increase in remuneration of Mr. Basudeo N. Singh (DIN: 00760310) as Executive Chairman of the Company for a period of 5 consecutive years w.e.f 1st April, 2020. d. Approved the appointment of Mr. Narendra Kumar Aneja (DIN:00124302) as an Additional Director, designated as Independent Director on the Board of Directors of the Company w.e.f 16th Mar, 2020.
07-02-2020
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 This is to inform you that US FDA had conducted an inspection of the Company's manufacturing facility located at St. Louis, USA from 27th January, 2020 to 06th February, 2020. At the end of the inspection, the Company has received Form 483 with three (3) observations. The Company shall submit to US FDA within the stipulated timeline, a detailed response to close out all the observations associated with this inspection. Kindly take the same on record.
07-02-2020
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q3FY20 and 9MFY20 financial results will be held on Friday, 07th February, 2020 at 05.00 P.M. Please find attached herewith the conference call details. Kindly take note of the same.
30-01-2020
Bigul

Alkem Laboratories Ltd - 539523 - Corporate Action-Board to consider Dividend

 The Board of Directors of the Company in its meeting to be held on 07th February, 2020 shall consider and approve Interim Dividend for the Financial Year 2019-2020.
29-01-2020
Bigul

Alkem Laboratories Ltd - 539523 - Board to consider Interim Dividend

 Alkem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 07, 2020, inter alia, to consider the following;1. To Consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2019; and2. To consider and approve Interim Dividend for the Financial Year 2019-2020.
29-01-2020
Bigul

Alkem Laboratories Ltd - 539523 - Corporate Action - Fixes Record Date As 15Th February, 2020

 The record date for the purpose of payment of interim dividend for the Financial Year 2019-2020, would be Saturday, 15th February, 2020, subject to declaration of the said interim dividend by the Board of Directors in its meeting to be held on 7th February, 2020.
29-01-2020
Bigul

Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of The Company Scheduled To Be Held On 7Th February, 2020.

 Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2020 ,inter alia, to consider and approve (i) the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2019; and (ii) Interim Dividend for the Financial Year 2019-2020. The record date for the purpose of payment of interim dividend for the Financial Year 2019-2020, would be Saturday, 15th February, 2020, subject to declaration of the said interim dividend by the Board of Directors in its meeting to be held on 7th February, 2020. Kindly take note of the same.
29-01-2020
Bigul

Alkem Laboratories Ltd - 539523 - Shareholding for the Period Ended December 31, 2019

 Alkem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
08-01-2020
Bigul

Alkem Laboratories Ltd - 539523 - Statement Of Investor Complaints For The Quarter Ended December 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Manish NarangDesignation :- Company Secretary and Compliance Officer
06-01-2020
Bigul

Company news: Alkem Laboratories

 Alkem Laboratories has entered into an agreement with AbbVie Inc, US, for acquisition of certain assets related to API Dronabinol for $10 million, plu
01-01-2020
Next Page
Close

Let's Open Free Demat Account